According to Latest Study, the global market for Immune Drugs should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

China Immune Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

The United States Immune Drugs market should grow from US$ million in 2023 to US$ million by 2030, with a CAGR of % for the period of 2024-2030.

In terms of type, Immune Boosting Drugs segment holds a share about % in 2024 and will reach % in 2030; while in terms of application, Hospital has a share approximately % in 2023 and will grow at a CAGR % during 2024 and 2030.

The global key manufacturers of Immune Drugs include Antares Pharma, Inc., UCB, Incyte, GSK, Takeda, 3S Bio, Horizo​​n Therapeutics, Bristol-Myers Squibb (BMS and Astellas, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

This report aims to provide a comprehensive study of the global market for Immune Drugs. Report Highlights:

(1) Global Immune Drugs market size (sales volume & revenue), history data from 2019-2023 and forecast data from 2024 to 2030.

(2) Global Immune Drugs market competitive situation, sales, revenue, price and market share, from 2019 to 2023.

(3) China Immune Drugs market competitive situation, sales, revenue, price and market share, from 2019 to 2023.

(4) Global Immune Drugs segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Immune Drugs segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Immune Drugs, capacity, production and trends.

(7) Immune Drugs industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Immune Boosting Drugs

Immunosuppressant Drugs

Market segment by application, can be divided into

Hospital

Clinic

Surgery Center

Others

Market segment by players, this report covers

Antares Pharma, Inc.

UCB

Incyte

GSK

Takeda

3S Bio

Horizo​​n Therapeutics

Bristol-Myers Squibb (BMS

Astellas

Eli Lilly

Mitsubishi Tanabe Pharma

Biogen

Pfizer

Sanofi

Roche

Novartis

Johnson & Johnson (J&J)

Amgen

Abbvi

1 Market Overview

1.1 Immune Drugs Definition

1.2 Global Immune Drugs Market Size and Forecast

1.2.1 By Revenue, Global Immune Drugs Market Size, 2019-2030

1.2.2 By Sales Volume, Global Immune Drugs Market Size, 2019-2030

1.2.3 Global Immune Drugs Price Trend, 2019-2030

1.3 China Immune Drugs Market Size and Forecast

1.3.1 By Revenue, China Immune Drugs Market Size, 2019-2030

1.3.2 By Sales Volume, China Immune Drugs Market Size, 2019-2030

1.3.3 China Immune Drugs Price Trend, 2019-2030

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Immune Drugs Share in Global Market, 2019-2030

1.4.2 By Sales Volume, China Immune Drugs Share in Global Market, 2019-2030

1.4.3 Immune Drugs Market Size: China VS Global, 2019-2030

1.5 Immune Drugs Market Dynamics

1.5.1 Immune Drugs Market Drivers

1.5.2 Immune Drugs Market Restraints

1.5.3 Immune Drugs Industry Trends

1.5.4 Immune Drugs Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Immune Drugs Revenue by Company, 2019-2024

2.2 Global Immune Drugs Sales Volume by Company, 2019-2024

2.3 Global Immune Drugs Price by Company, 2019-2024

2.4 Global Immune Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Immune Drugs Concentration Ratio

2.6 Global Immune Drugs Mergers & Acquisitions, Expansion Plans

2.7 Global Immune Drugs Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Immune Drugs Revenue by Company, 2019-2024

3.2 China Immune Drugs Sales Volume by Company, 2019-2024

3.3 China Immune Drugs Immune Drugs Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Immune Drugs Market, Sales Percentage of Local Players VS Foreign Players (2019-2024)

3.5 Chinese Local Players, Immune Drugs Domestic VS Export

3.6 China Market, Immune Drugs Import & Export

3.6.1 China Market, Immune Drugs Import & Export, 2019-2030

3.6.2 China Immune Drugs Import & Export Trends

3.6.3 Main Sources of China Immune Drugs Import

3.6.4 Export Destination of China Immune Drugs

4 Immune Drugs Production by Region

4.1 Global Immune Drugs Capacity, Production and Capacity Utilization, 2019-2030

4.2 Global Geographic Distribution of Immune Drugs Manufacturers

4.3 Global Major Manufacturers, Immune Drugs Capacity Expansion and Future Plans

4.4 Global Immune Drugs Capacity by Region

4.5 Global Immune Drugs Production by Region

4.5.1 Global Immune Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030

4.5.2 Global Immune Drugs Production by Region, 2019-2024

4.5.3 Global Immune Drugs Production Market Share & Forecast by Region, 2019-2030

5 Industry Chain Analysis

5.1 Immune Drugs Industry Chain

5.2 Immune Drugs Upstream Analysis

5.2.1 Immune Drugs Core Raw Materials

5.2.2 Main Manufacturers of Immune Drugs Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Immune Drugs Production Mode

5.6 Immune Drugs Procurement Model

5.7 Immune Drugs Industry Sales Model and Sales Channels

5.7.1 Immune Drugs Sales Model

5.7.2 Immune Drugs Typical Distributors

6 Sights by Type

6.1 Immune Drugs Classification

6.1.1 Immune Boosting Drugs

6.1.2 Immunosuppressant Drugs

6.2 By Type, Global Immune Drugs Market Size & CAGR, 2019 VS 2024 VS 2030

6.3 By Type, Global Immune Drugs Revenue, 2019-2030

6.4 By Type, Global Immune Drugs Sales Volume, 2019-2030

6.5 By Type, Global Immune Drugs Price, 2019-2030

7 Sights by Application

7.1 Immune Drugs Segment by Application

7.1.1 Hospital

7.1.2 Clinic

7.1.3 Surgery Center

7.1.4 Others

7.2 By Application, Global Immune Drugs Market Size & CAGR, 2019 VS 2024 VS 2030

7.3 By Application, Global Immune Drugs Revenue, 2019-2030

7.4 By Application, Global Immune Drugs Sales Volume, 2019-2030

7.5 By Application, Global Immune Drugs Price, 2019-2030

8 Sales Sights by Region

8.1 By Region, Global Immune Drugs Market Size, 2019 VS 2024 VS 2030

8.2 By Region, Global Immune Drugs Revenue, 2019-2030

8.3 By Region, Global Immune Drugs Sales Volume, 2019-2030

8.4 North America

8.4.1 North America Immune Drugs Market Size & Forecasts, 2019-2030

8.4.2 By Country, North America Immune Drugs Market Size Market Share

8.5 Europe

8.5.1 Europe Immune Drugs Market Size & Forecasts, 2019-2030

8.5.2 By Country, Europe Immune Drugs Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Immune Drugs Market Size & Forecasts, 2019-2030

8.6.2 By Country/Region, Asia Pacific Immune Drugs Market Size Market Share

8.7 South America

8.7.1 South America Immune Drugs Market Size & Forecasts, 2019-2030

8.7.2 By Country, South America Immune Drugs Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Immune Drugs Market Size & CAGR，2019 VS 2024 VS 2030

9.2 By Country, Global Immune Drugs Revenue, 2019-2030

9.3 By Country, Global Immune Drugs Sales Volume, 2019-2030

9.4 U.S.

9.4.1 U.S. Immune Drugs Market Size, 2019-2030

9.4.2 By Company, U.S. Immune Drugs Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Immune Drugs Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Immune Drugs Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Immune Drugs Market Size, 2019-2030

9.5.2 By Company, Europe Immune Drugs Sales Volume Market Share, 2022

9.5.3 By Type, Europe Immune Drugs Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Immune Drugs Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Immune Drugs Market Size, 2019-2030

9.6.2 By Company, China Immune Drugs Sales Volume Market Share, 2022

9.6.3 By Type, China Immune Drugs Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Immune Drugs Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Immune Drugs Market Size, 2019-2030

9.7.2 By Company, Japan Immune Drugs Sales Volume Market Share, 2022

9.7.3 By Type, Japan Immune Drugs Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Immune Drugs Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Immune Drugs Market Size, 2019-2030

9.8.2 By Company, South Korea Immune Drugs Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Immune Drugs Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Immune Drugs Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Immune Drugs Market Size, 2019-2030

9.9.2 By Company, Southeast Asia Immune Drugs Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Immune Drugs Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Immune Drugs Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Immune Drugs Market Size, 2019-2030

9.10.2 By Company, India Immune Drugs Sales Volume Market Share, 2022

9.10.3 By Type, India Immune Drugs Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Immune Drugs Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Immune Drugs Market Size, 2019-2030

9.11.2 By Company, Middle East & Asia Immune Drugs Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Immune Drugs Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Immune Drugs Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Antares Pharma, Inc.

10.1.1 Antares Pharma, Inc. Company Information, Head Office, Market Area and Industry Position

10.1.2 Antares Pharma, Inc. Immune Drugs Models, Specifications and Application

10.1.3 Antares Pharma, Inc. Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.1.4 Antares Pharma, Inc. Company Profile and Main Business

10.1.5 Antares Pharma, Inc. Recent Developments

10.2 UCB

10.2.1 UCB Company Information, Head Office, Market Area and Industry Position

10.2.2 UCB Immune Drugs Models, Specifications and Application

10.2.3 UCB Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.2.4 UCB Company Profile and Main Business

10.2.5 UCB Recent Developments

10.3 Incyte

10.3.1 Incyte Company Information, Head Office, Market Area and Industry Position

10.3.2 Incyte Immune Drugs Models, Specifications and Application

10.3.3 Incyte Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.3.4 Incyte Company Profile and Main Business

10.3.5 Incyte Recent Developments

10.4 GSK

10.4.1 GSK Company Information, Head Office, Market Area and Industry Position

10.4.2 GSK Immune Drugs Models, Specifications and Application

10.4.3 GSK Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.4.4 GSK Company Profile and Main Business

10.4.5 GSK Recent Developments

10.5 Takeda

10.5.1 Takeda Company Information, Head Office, Market Area and Industry Position

10.5.2 Takeda Immune Drugs Models, Specifications and Application

10.5.3 Takeda Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.5.4 Takeda Company Profile and Main Business

10.5.5 Takeda Recent Developments

10.6 3S Bio

10.6.1 3S Bio Company Information, Head Office, Market Area and Industry Position

10.6.2 3S Bio Immune Drugs Models, Specifications and Application

10.6.3 3S Bio Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.6.4 3S Bio Company Profile and Main Business

10.6.5 3S Bio Recent Developments

10.7 Horizo​​n Therapeutics

10.7.1 Horizo​​n Therapeutics Company Information, Head Office, Market Area and Industry Position

10.7.2 Horizo​​n Therapeutics Immune Drugs Models, Specifications and Application

10.7.3 Horizo​​n Therapeutics Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.7.4 Horizo​​n Therapeutics Company Profile and Main Business

10.7.5 Horizo​​n Therapeutics Recent Developments

10.8 Bristol-Myers Squibb (BMS

10.8.1 Bristol-Myers Squibb (BMS Company Information, Head Office, Market Area and Industry Position

10.8.2 Bristol-Myers Squibb (BMS Immune Drugs Models, Specifications and Application

10.8.3 Bristol-Myers Squibb (BMS Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.8.4 Bristol-Myers Squibb (BMS Company Profile and Main Business

10.8.5 Bristol-Myers Squibb (BMS Recent Developments

10.9 Astellas

10.9.1 Astellas Company Information, Head Office, Market Area and Industry Position

10.9.2 Astellas Immune Drugs Models, Specifications and Application

10.9.3 Astellas Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.9.4 Astellas Company Profile and Main Business

10.9.5 Astellas Recent Developments

10.10 Eli Lilly

10.10.1 Eli Lilly Company Information, Head Office, Market Area and Industry Position

10.10.2 Eli Lilly Immune Drugs Models, Specifications and Application

10.10.3 Eli Lilly Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.10.4 Eli Lilly Company Profile and Main Business

10.10.5 Eli Lilly Recent Developments

10.11 Mitsubishi Tanabe Pharma

10.11.1 Mitsubishi Tanabe Pharma Company Information, Head Office, Market Area and Industry Position

10.11.2 Mitsubishi Tanabe Pharma Immune Drugs Models, Specifications and Application

10.11.3 Mitsubishi Tanabe Pharma Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.11.4 Mitsubishi Tanabe Pharma Company Profile and Main Business

10.11.5 Mitsubishi Tanabe Pharma Recent Developments

10.12 Biogen

10.12.1 Biogen Company Information, Head Office, Market Area and Industry Position

10.12.2 Biogen Immune Drugs Models, Specifications and Application

10.12.3 Biogen Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.12.4 Biogen Company Profile and Main Business

10.12.5 Biogen Recent Developments

10.13 Pfizer

10.13.1 Pfizer Company Information, Head Office, Market Area and Industry Position

10.13.2 Pfizer Immune Drugs Models, Specifications and Application

10.13.3 Pfizer Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.13.4 Pfizer Company Profile and Main Business

10.13.5 Pfizer Recent Developments

10.14 Sanofi

10.14.1 Sanofi Company Information, Head Office, Market Area and Industry Position

10.14.2 Sanofi Immune Drugs Models, Specifications and Application

10.14.3 Sanofi Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.14.4 Sanofi Company Profile and Main Business

10.14.5 Sanofi Recent Developments

10.15 Roche

10.15.1 Roche Company Information, Head Office, Market Area and Industry Position

10.15.2 Roche Immune Drugs Models, Specifications and Application

10.15.3 Roche Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.15.4 Roche Company Profile and Main Business

10.15.5 Roche Recent Developments

10.16 Novartis

10.16.1 Novartis Company Information, Head Office, Market Area and Industry Position

10.16.2 Novartis Immune Drugs Models, Specifications and Application

10.16.3 Novartis Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.16.4 Novartis Company Profile and Main Business

10.16.5 Novartis Recent Developments

10.17 Johnson & Johnson (J&J)

10.17.1 Johnson & Johnson (J&J) Company Information, Head Office, Market Area and Industry Position

10.17.2 Johnson & Johnson (J&J) Immune Drugs Models, Specifications and Application

10.17.3 Johnson & Johnson (J&J) Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.17.4 Johnson & Johnson (J&J) Company Profile and Main Business

10.17.5 Johnson & Johnson (J&J) Recent Developments

10.18 Amgen

10.18.1 Amgen Company Information, Head Office, Market Area and Industry Position

10.18.2 Amgen Immune Drugs Models, Specifications and Application

10.18.3 Amgen Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.18.4 Amgen Company Profile and Main Business

10.18.5 Amgen Recent Developments

10.19 Abbvi

10.19.1 Abbvi Company Information, Head Office, Market Area and Industry Position

10.19.2 Abbvi Immune Drugs Models, Specifications and Application

10.19.3 Abbvi Immune Drugs Sales Volume, Revenue, Price and Gross Margin, 2019-2024

10.19.4 Abbvi Company Profile and Main Business

10.19.5 Abbvi Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Immune Drugs Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Immune Drugs Market Restraints

Table 3. Immune Drugs Market Trends

Table 4. Immune Drugs Industry Policy

Table 5. Global Immune Drugs Revenue by Company, 2019-2024, US$ million

Table 6. Global Immune Drugs Revenue Market Share by Company, 2019-2024

Table 7. Global Immune Drugs Sales Volume by Company, 2019-2024, (K Units)

Table 8. Global Immune Drugs Sales Volume Market Share by Company, 2019-2024

Table 9. Global Immune Drugs Price by Company, 2019-2024, (US$/Unit)

Table 10. Global Immune Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Immune Drugs Mergers & Acquisitions, Expansion Plans

Table 12. Global Immune Drugs Manufacturers Product Type

Table 13. China Immune Drugs Revenue by Company, 2019-2024, US$ million

Table 14. China Immune Drugs Revenue Market Share by Company, 2019-2024

Table 15. China Immune Drugs Sales Volume by Company, 2019-2024, (K Units)

Table 16. China Immune Drugs Sales Volume Market Share by Company, 2019-2024

Table 17. China Market, Immune Drugs Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Immune Drugs Import & Export Trends

Table 19. Main Sources of China Immune Drugs Import

Table 20. Export Destination of China Immune Drugs

Table 21. Global Headquarters and Manufacturing Base of Immune Drugs Manufacturers

Table 22. Global Major Manufacturers, Immune Drugs Capacity Expansion and Future Plans

Table 23. Global Immune Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 24. Global Immune Drugs Production by Region, 2019-2024, (K Units)

Table 25. Global Immune Drugs Production Forecast by Region, 2024-2030, (K Units)

Table 26. Global Key Players of Immune Drugs Upstream (Raw Materials)

Table 27. Global Immune Drugs Typical Customers

Table 28. Immune Drugs Typical Distributors

Table 29. By Type, Global Immune Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Application, Global Immune Drugs Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 31. By Region, Global Immune Drugs Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 32. By Region, Global Immune Drugs Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Immune Drugs Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Immune Drugs Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 35. By Country, Global Immune Drugs Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Immune Drugs Revenue Market Share, 2019-2030

Table 37. By Country, Global Immune Drugs Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Immune Drugs Sales Volume Market Share, 2019-2030

Table 39. Antares Pharma, Inc. Company Information, Head Office, Market Area and Industry Position

Table 40. Antares Pharma, Inc. Immune Drugs Models, Specifications and Application

Table 41. Antares Pharma, Inc. Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. Antares Pharma, Inc. Company Profile and Main Business

Table 43. Antares Pharma, Inc. Recent Developments

Table 44. UCB Company Information, Head Office, Market Area and Industry Position

Table 45. UCB Immune Drugs Models, Specifications and Application

Table 46. UCB Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. UCB Company Profile and Main Business

Table 48. UCB Recent Developments

Table 49. Incyte Company Information, Head Office, Market Area and Industry Position

Table 50. Incyte Immune Drugs Models, Specifications and Application

Table 51. Incyte Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. Incyte Company Profile and Main Business

Table 53. Incyte Recent Developments

Table 54. GSK Company Information, Head Office, Market Area and Industry Position

Table 55. GSK Immune Drugs Models, Specifications and Application

Table 56. GSK Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. GSK Company Profile and Main Business

Table 58. GSK Recent Developments

Table 59. Takeda Company Information, Head Office, Market Area and Industry Position

Table 60. Takeda Immune Drugs Models, Specifications and Application

Table 61. Takeda Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. Takeda Company Profile and Main Business

Table 63. Takeda Recent Developments

Table 64. 3S Bio Company Information, Head Office, Market Area and Industry Position

Table 65. 3S Bio Immune Drugs Models, Specifications and Application

Table 66. 3S Bio Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. 3S Bio Company Profile and Main Business

Table 68. 3S Bio Recent Developments

Table 69. Horizo​​n Therapeutics Company Information, Head Office, Market Area and Industry Position

Table 70. Horizo​​n Therapeutics Immune Drugs Models, Specifications and Application

Table 71. Horizo​​n Therapeutics Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Horizo​​n Therapeutics Company Profile and Main Business

Table 73. Horizo​​n Therapeutics Recent Developments

Table 74. Bristol-Myers Squibb (BMS Company Information, Head Office, Market Area and Industry Position

Table 75. Bristol-Myers Squibb (BMS Immune Drugs Models, Specifications and Application

Table 76. Bristol-Myers Squibb (BMS Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Bristol-Myers Squibb (BMS Company Profile and Main Business

Table 78. Bristol-Myers Squibb (BMS Recent Developments

Table 79. Astellas Company Information, Head Office, Market Area and Industry Position

Table 80. Astellas Immune Drugs Models, Specifications and Application

Table 81. Astellas Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Astellas Company Profile and Main Business

Table 83. Astellas Recent Developments

Table 84. Eli Lilly Company Information, Head Office, Market Area and Industry Position

Table 85. Eli Lilly Immune Drugs Models, Specifications and Application

Table 86. Eli Lilly Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Eli Lilly Company Profile and Main Business

Table 88. Eli Lilly Recent Developments

Table 89. Mitsubishi Tanabe Pharma Company Information, Head Office, Market Area and Industry Position

Table 90. Mitsubishi Tanabe Pharma Immune Drugs Models, Specifications and Application

Table 91. Mitsubishi Tanabe Pharma Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Mitsubishi Tanabe Pharma Company Profile and Main Business

Table 93. Mitsubishi Tanabe Pharma Recent Developments

Table 94. Biogen Company Information, Head Office, Market Area and Industry Position

Table 95. Biogen Immune Drugs Models, Specifications and Application

Table 96. Biogen Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Biogen Company Profile and Main Business

Table 98. Biogen Recent Developments

Table 99. Pfizer Company Information, Head Office, Market Area and Industry Position

Table 100. Pfizer Immune Drugs Models, Specifications and Application

Table 101. Pfizer Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Pfizer Company Profile and Main Business

Table 103. Pfizer Recent Developments

Table 104. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 105. Sanofi Immune Drugs Models, Specifications and Application

Table 106. Sanofi Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Sanofi Company Profile and Main Business

Table 108. Sanofi Recent Developments

Table 109. Roche Company Information, Head Office, Market Area and Industry Position

Table 110. Roche Immune Drugs Models, Specifications and Application

Table 111. Roche Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 112. Roche Company Profile and Main Business

Table 113. Roche Recent Developments

Table 114. Novartis Company Information, Head Office, Market Area and Industry Position

Table 115. Novartis Immune Drugs Models, Specifications and Application

Table 116. Novartis Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 117. Novartis Company Profile and Main Business

Table 118. Novartis Recent Developments

Table 119. Johnson & Johnson (J&J) Company Information, Head Office, Market Area and Industry Position

Table 120. Johnson & Johnson (J&J) Immune Drugs Models, Specifications and Application

Table 121. Johnson & Johnson (J&J) Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 122. Johnson & Johnson (J&J) Company Profile and Main Business

Table 123. Johnson & Johnson (J&J) Recent Developments

Table 124. Amgen Company Information, Head Office, Market Area and Industry Position

Table 125. Amgen Immune Drugs Models, Specifications and Application

Table 126. Amgen Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 127. Amgen Company Profile and Main Business

Table 128. Amgen Recent Developments

Table 129. Abbvi Company Information, Head Office, Market Area and Industry Position

Table 130. Abbvi Immune Drugs Models, Specifications and Application

Table 131. Abbvi Immune Drugs Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 132. Abbvi Company Profile and Main Business

Table 133. Abbvi Recent Developments

List of Figure

Figure 1. Immune Drugs Picture

Figure 2. By Revenue, Global Immune Drugs Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Immune Drugs Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Immune Drugs Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Immune Drugs Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Immune Drugs Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Immune Drugs Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Immune Drugs Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Immune Drugs Share of Global Market, 2019-2030

Figure 10. Global Immune Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Immune Drugs Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Immune Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Immune Drugs Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Immune Drugs Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 15. Chinese Local Players, Proportion of Immune Drugs Domestic VS Export, 2022

Figure 16. Global Immune Drugs Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Immune Drugs Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Immune Drugs Production Market Share & Forecast by Region, 2019-2030

Figure 19. Immune Drugs Industry Chain

Figure 20. Immune Drugs Procurement Model

Figure 21. Immune Drugs Sales Model

Figure 22. Immune Drugs Sales Channels, Direct Sales and Distribution

Figure 23. Immune Boosting Drugs

Figure 24. Immunosuppressant Drugs

Figure 25. By Type, Global Immune Drugs Revenue, 2019-2030, US$ Million

Figure 26. By Type, Global Immune Drugs Revenue Market Share, 2019-2030

Figure 27. By Type, Global Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 28. By Type, Global Immune Drugs Sales Volume Market Share, 2019-2030

Figure 29. By Type, Global Immune Drugs Price, 2019-2030, (US$/Unit)

Figure 30. Hospital

Figure 31. Clinic

Figure 32. Surgery Center

Figure 33. Others

Figure 34. By Application, Global Immune Drugs Revenue, 2019-2030, US$ Million

Figure 35. By Application, Global Immune Drugs Revenue Market Share, 2019-2030

Figure 36. By Application, Global Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 37. By Application, Global Immune Drugs Sales Volume Market Share, 2019-2030

Figure 38. By Application, Global Immune Drugs Price, 2019-2030, (US$/Unit)

Figure 39. By Region, Global Immune Drugs Revenue Market Share, 2019-2030

Figure 40. By Region, Global Immune Drugs Sales Volume Market Share, 2019-2030

Figure 41. North America Immune Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 42. By Country, North America Immune Drugs Revenue Market Share, 2022

Figure 43. Europe Immune Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, Europe Immune Drugs Revenue Market Share, 2022

Figure 45. Asia Pacific Immune Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 46. By Country/Region, Asia Pacific Immune Drugs Revenue Market Share, 2022

Figure 47. South America Immune Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 48. By Country, South America Immune Drugs Revenue Market Share, 2022

Figure 49. Middle East & Africa Immune Drugs Revenue & Forecasts, 2019-2030, US$ Million

Figure 50. U.S. Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 51. By Company, U.S. Immune Drugs Market Share, 2022

Figure 52. By Type, U.S. Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 53. By Application, U.S. Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 54. Europe Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 55. By Company, Europe Immune Drugs Market Share, 2022

Figure 56. By Type, Europe Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 57. By Application, Europe Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 58. China Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 59. By Company, China Immune Drugs Market Share, 2022

Figure 60. By Type, China Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 61. By Application, China Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 62. Japan Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 63. By Company, Japan Immune Drugs Market Share, 2022

Figure 64. By Type, Japan Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 65. By Application, Japan Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 66. South Korea Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 67. By Company, South Korea Immune Drugs Market Share, 2022

Figure 68. By Type, South Korea Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 69. By Application, South Korea Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 70. Southeast Asia Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 71. By Company, Southeast Asia Immune Drugs Market Share, 2022

Figure 72. By Type, Southeast Asia Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 73. By Application, Southeast Asia Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 74. India Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 75. By Company, India Immune Drugs Market Share, 2022

Figure 76. By Type, India Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 77. By Application, India Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 78. Middle East & Asia Immune Drugs Sales Volume, 2019-2030, (K Units)

Figure 79. By Company, Middle East & Asia Immune Drugs Market Share, 2022

Figure 80. By Type, Middle East & Asia Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 81. By Application, Middle East & Asia Immune Drugs Sales Volume Market Share, 2022 VS 2029

Figure 82. Research Methodology

Figure 83. Breakdown of Primary Interviews

Figure 84. Bottom-up Approaches

Figure 85. Top-down Approaches

Methodology/Research Approach

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Research Programs/Design

Historical Data (2015-2019)	Industry Trends Competitive Landscape By Company Expansion Mergers and Acquisitions Market Segment by Type by Application By Regions/ Geography	Value Status and Outlook Value for Major Players Market Share Growth Rate Present Situation Analysis Value Market Share Growth Rate Present Situation Analysis
Influencing Factors	Market Environment Government Policy Technological Changes Market Risks	Market Drivers Growing Demand of Downstream Reduction in Cost
Market Forecast (2021-2026)	Overall Size by Type by Application By Regions/Geography	Key Data (Value) Market Share Growth Rate CAGR (2021-2026)

Market Size Estimation

Top-down and bottom-up approaches are used to validate the global Voluntary Carbon Offset market size market and estimate the market size for Company, regions segments, product segments and Application (end users).

The market estimations in this report are based on the marketed sale price of Voluntary Carbon Offset (excluding any discounts provided by the player, distributor, wholesaler or traders). The percentage splits, market share, and breakdowns of the product segments are derived on the basis of weights assigned to each of the segments on the basis of their utilization rate and average sale price. The regional splits of the overall Voluntary Carbon Offset market and its sub-segments are based on the percentage adoption or utilization of the given product in the respective region or country.

Major Company in the market is identified through secondary research and their market revenues determined through primary and secondary research. Secondary research included the research of the annual and financial reports of the top Company; whereas, primary research included extensive interviews of key opinion leaders and industry experts such as experienced front-line staff, directors, CEOs and marketing executives. The percentage splits, market share, Growth Rate and breakdowns of the product markets are determined through using secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Market Intellix and presented in this report

The following figure shows an illustrative representation of the overall market size estimation process used for this study.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.

Data Source

Secondary Sources

Secondary sources include such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, etc. This research study involves the usage of widespread secondary sources, directories, databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), and TRADING ECONOMICS, and News Network, statista, Federal Reserve Economic Data, annual reports, BIS Statistics, ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and Hospitals study of the Voluntary Carbon Offset market. It was also used to obtain important information about the top companies, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Market Size	Segmental value Geographic Penetration Product Adoption Rate for Different market	Journals, Websites, and Press Releases Annual Reports and SEC Filings Company Websites and Press Releases Public and Paid Databases Market Intellix Data Repository
Market Position of Top Company	Product Financials Geographic value Mix Total Company value Business/Segmental value Mix
Qualitative Analysis	Influence Factors Market Potential Market Risks and Opportunities Industry Trends Geographical Features Government Policies	Company Websites and Press Releases Public and Paid Databases Annual Reports Industry Associations Market Intellix Data Repository

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product Company (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end use (product buyers), and related key executives from various key companies and organizations operating in the global market.

Primary research was conducted to identify segmentation Type, product price range, product Application, key Company, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.

Key Executives Interviewed

Key Data Information from Primary Sources

Primary Sources	Parameters	Key Data
Market Segments(by Application, by Type)	Value by Type Status and Forecast Value by Application Value by Regions, Status and Forecast (2021-2026)	Value Market Share by Type Value Growth Rate by Type Value by Application Percentage and Growth Rate by Application Value Growth Rate and Market Share by Regions Market Size Status and Forecast (2021-2026)
Total Market	Overall Size, Status and Forecast	Market Size Status and Forecast (2021-2026)